Cargando…
Cervical Cancer Screening after Perimenopause: How Is Human Papillomavirus Test Performed?
Cervical cancer is the third most prevalent cancer in women around the world. Recently in Korea, the incidence of cervical cancer has decreased, but in all stages of cervical intraepithelial neoplasia (CIN), CIN has shown a 91% increase from 1999 to 2008. Persistent human papillomavirus (HPV) infect...
Autor principal: | Chung, Soo-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Menopause
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016505/ https://www.ncbi.nlm.nih.gov/pubmed/27617239 http://dx.doi.org/10.6118/jmm.2016.22.2.65 |
Ejemplares similares
-
Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005) -
Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023) -
Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
por: Kim, Mee-seon, et al.
Publicado: (2020) -
By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016) -
Human papillomavirus testing as a primary screening tool for cervical cancer
por: Cho, Hyun-Woong, et al.
Publicado: (2021)